Biography:
The author is a clinician in HPB surgery with an interest in Hepatobiliary and Pancreatic Cancer research including Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). Currently, he is working in HPB in University Hospital of Southampton (UK). He hold a PhD degree from the Pancreas Unit in the University of Verona and has worked in several prestigious university around the world including Yale University and King’s College Hospital.
Gemcitabine-based neoadjuvant treatments in borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC): A systematic review and meta-analysis of individual patient data